Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Neoplasms 2 Breast Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Hodgkin Disease 1 Glioma 1 Glioblastoma 1 Fatigue 1 Cytokine Release Syndrome 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Astrocytoma 1

Interventions

Temozolomide 111 Radiotherapy 60 Carboplatin 30 Bevacizumab 30 Magnetic Resonance Spectroscopy 28 Carmustine 28 Filgrastim 23 Surgical Procedures, Operative 22 Irinotecan 22 Radiation 17 Lomustine 16 Vincristine 15 Etoposide 15 Specimen Handling 13 Peripheral Blood Stem Cell Transplantation 13 O(6)-benzylguanine 13 Radiotherapy, Intensity-Modulated 12 Procarbazine 11 Erlotinib Hydrochloride 11 Cyclophosphamide 11 Chemotherapy, Adjuvant 11 sargramostim 10 Thiotepa 10 Cisplatin 10 Flucytosine 9 Everolimus 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Granulocyte Colony-Stimulating Factor 8 Vorinostat 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Astrocytoma × Neuropsychological Tests × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡